DUBLIN – Pfizer Inc. (New York) is swapping its New York home for an Irish domicile by combining with Allergan plc (Dublin) in an all-share deal, which values the latter firm at $160 billion and which will cut Pfizer's tax rate from its reported rate of 25.5 percent in 2014 to 17 percent to 18 percent for the combined company. Read More
